Marina Elli

Dr. Marina Elli

AAT-Advanced Analytical Technologies Srl, Via P. Majavacca 12, 29107 Fiorenzuola d'Arda (Piacenza), Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CSClaudio Salaris
Claudio Salaris
MSMelania Scarpa
Melania Scarpa
MEMarina Elli
Marina Elli
ABAlice Bertolini
Alice Bertolini
Simone GuglielmettiSimone Guglielmetti
Simone Guglielmetti
ICIgnazio Castagliuolo
Ignazio Castagliuolo
SARS-CoV-2 is a newly emerging virus that currently lacks curative treatments. Lactoferrin (LF) is a naturally occurring non-toxic glycoprotein with broad-spectrum antiviral, immunomodulatory and anti-inflammatory effects. In this study, we assessed the potential of LF in the prevention of SARS-CoV-2 infection in vitro. Antiviral immune response gene expression was analyzed by qRT-PCR in uninfected Caco-2 intestinal epithelial cells treated with LF. An infection assay for SARS-CoV-2 was performed in Caco-2 cells treated or not with LF. SARS-CoV-2 titer was determined by qRT-PCR, plaque assay and immunostaining. Inflammatory and anti-inflammatory cytokine production was determined by qRT-PCR. LF significantly induced the expression of IFNA1, IFNB1, TLR3, TLR7, IRF3, IRF7 and MAVS genes. Furthermore, LF partially inhibited SARS-CoV-2 infection and replication in Caco-2 intestinal epithelial cells. Our in vitro data support LF as an immune modulator of the antiviral immune response with moderate effects against SARS-CoV-2 infection.



1 September 2008 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
MEMarina Elli
Marina Elli
DCDaniela Cattivelli
Daniela Cattivelli
SSSara Soldi
Sara Soldi
MBMarzia Bonatti
Marzia Bonatti
Lorenzo MorelliLorenzo Morelli
Lorenzo Morelli
To assess the effects of the consumption of psyllium seed husk on fecal bifidobacteria in healthy women and the ability of fecal bifidobacteria to metabolize psyllium seed husk in vitro. Poor microbiologic evidences are nowadays available concerning the ability of psyllium seed husk to promote the growth of bifidobacteria in human gut. Eleven healthy women consumed 7.0 g/d of psyllium seed husk for 1 month. Viability of bifidobacteria in feces was assessed at different time points. In vivo results showed that the average fecal content of viable bifidobacteria was not significantly affected even if fecal counts were found to increase significantly after treatment in 6 out of 11 women having low initial concentration. In vitro trials conducted on bifidobacteria strains isolated from treated women failed to confirm the prebiotic potential of undigested psyllium seed husk, whereas treatment with simulated gastric and pancreatic juices and mimicking physical and chemical alterations during human gut transit allowed fecal Bifidobacterium isolates to metabolize psyllium seed husk as carbon source in a growth medium deprived of sugar. Psyllium seed husk can be metabolized by bifidobacteria only after partial hydrolysis. Bifidogenic potential can be detected in healthy women only in case of low level of fecal bifidobacteria before treatment.

23 November 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Cinzia FerrarisCinzia Ferraris
Cinzia Ferraris
MEMarina Elli
Marina Elli
Anna TagliabueAnna Tagliabue
Anna Tagliabue
The human intestinal tract is colonized by a resilient integrated ecosystem represented by a complex consortium of trillions of microbes

1 January 2022 in International Journal of Dentistry
Verified
Journal Article
Open access
PDF file
GGGiuseppe Giannini
Giuseppe Giannini
IRIrene Ragusa
Irene Ragusa
GNGiulia Nerina Nardone
Giulia Nerina Nardone
SSSara Soldi
Sara Soldi
MEMarina Elli
Marina Elli
EPEmilio Merlo Pich
Emilio Merlo Pich
Objective. Periodontitis is a common disorder that leads to the loss of both tooth and personal well‐being, contributing to worsen the risk for metabolic and cardiovascular diseases. Recently, probiotics, characterized by rapid oral dispersion, have been topically used. Here, we present data of a mucoadhesive gel containing probiotics, capable of ensuring a slow release of bacteria to prevent and treat periodontitis. Methods. An original mucoadhesive gel (AL0005) that is anhydrous and of food grade, loaded with the blend of lactobacilli and plants’ dry extracts, has been assayed. Results. The release kinetics of the bacterial mixture in different experimental models in vitro, including simulated saliva or physiological solutions, showed a significant and stable release for 5–8 hours. In one in vivo study of a mouse model of periodontitis, a locally applied mucoadhesive gel enriched with probiotic strains improved significantly the tissue pathology when compared with vehicle‐exposed mice. Conclusions. Together, the results suggest that this mucoadhesive gel can be useful in the normalization of the gum bacterial flora and improvement of the tissue pathology of gum disorders.